Fidelity International
RVMD icon

Fidelity International’s Revolution Medicines RVMD Stock Holding History

Fidelity International’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
5,447
+4,213
+341% +$615K ﹤0.01% 840
2026
Q1 		$120K Buy
+1,234
New +$125K ﹤0.01% 986
2021
Q1 		– Sell
-169
Closed -$7K – 1084
2020
Q4 		$7K Sell
169
-104,604
-100% -$4.14M ﹤0.01% 815
2020
Q3 		$3.65M Hold
104,773
– – ﹤0.01% 557
2020
Q2 		$3.31M Sell
104,773
-90,674
-46% -$2.85M ﹤0.01% 548
2020
Q1 		$4.28M Buy
+195,447
New +$5.41M 0.01% 526

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fidelity International's RVMD Position: Q2 2026 in Review

Fidelity International increased its Revolution Medicines (RVMD) stake by 341% in Q2 2026, buying an estimated $615K and bringing the position to 5,447 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Fidelity International first reported a position in RVMD in Q1 2020 and has held it in 6 quarters since. The position peaked at $4.28M in Q1 2020. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fidelity International held 5,447 shares of Revolution Medicines worth $1.02M as of Q2 2026.
  • Fidelity International bought 4,213 Revolution Medicines shares in Q2 2026, an estimated $615K.
  • Revolution Medicines made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #840 holding.
  • Fidelity International first reported a position in Revolution Medicines in Q1 2020 and has held it in 6 quarters since.
  • Fidelity International's Revolution Medicines position peaked at $4.28M in Q1 2020.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.